Cost/effectiveness analysis of two strategies for Helicobacter pylori eradication: Results of a prospective and randomized study in primary care setting;Analisis coste-efectividad de dos estrategias de erradicacion de Helicobacter pylori: Resultados de un estudio prospectivo y aleatorizado en atencion primaria

Medicina Clinica

Volumn 115, Issue 1, 2000, Pages 1-6

  Gomollón, Fernando ^b   Valdepérez, Javier ^a   Garuz, Roberto ^a   Fuentes, Javier ^c   Barrera, Fernando ^a   Malo, Juana ^a   Tirado, Marta ^a   Simón, Miguel Ángel ^c  

^a CENTRO DE SALUD DELICIAS SUR   (Spain)

^b NONE   (Spain)

^c NONE

Author keywords

Clarithromycin; Cost effectiveness; H. pylori; Quadruple treatment

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE; ANTIINFECTIVE AGENT; ANTIULCER AGENT; ORGANOMETALLIC COMPOUND; PENICILLIN DERIVATIVE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; ERADICATION THERAPY; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIMARY MEDICAL CARE; ADOLESCENT; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COMBINATION; DUODENUM ULCER; ECONOMICS; FEMALE; HELICOBACTER INFECTION; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STOMACH ULCER; TIME;

ADOLESCENT; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PENICILLINS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; STOMACH ULCER; TETRACYCLINE; TIME FACTORS;

EID: 0034600417     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71447-3     Document Type: Article

References (36)

1. Soll AH. Gastric, duodenal and stress ulcer. En: Sleisenger MH, Fordtran JS, editores. Gastrointestinal disease: pathophysiology, diagnosis, and management. Filadelfia: WB Saunders, 1993; 580-679.
2. Sáinz Samitier R, Gomollón Garcia F, Montoro Huguet M. Úlcera péptica. En: Vilardell F, editor. Enfermedades digestivas. Madrid: Libros Princeps, 1998; 581-622.
3. Graham DY. Evolution of concepts regarding Helicobacter pylori: from a cause of gastritis to a public health problem [editorial]. Am J Gastroenterol 1994; 4: 469-472.
4. Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven years follow-up. Lancet 1994; 343: 258-260.
5. Boixeda D, Gisbert JP, Cantón R, Álvarez Baleriola I, Bermejo F, Aller R et al. Helicobacter pylori, úlcera gástrica y antiinflamatorios no esteroides. Med Clin (Barc) 96; 106:209-212.
6. NIH Consensus Development Panel. Helicobacter pylori peptic ulcer disease. JAMA 1994; 272: 65-69.
7. The European Helicobacter pylori Study Group. Current European Concepts in the management of Helicobacier pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 8-13.
8. Lam SK, Talley NJ. Helicobacter pylori consensus. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori Infection. J Gastroenterol Hepatol 1998; 13: 1-12.
9. Badia X, Segú JL, Ollé A. Análisis coste-efectividad de diferentes estrategias para el tratamiento de la úlcera duodenal. PharmacoEconomics 1997; 11: 367-376.
10. Sonnenbeng A, Townsed WF. Costs of duodenal ulcer therapy with antibiotics. Arch Intern Med 1995; 155: 922-928.
11. Sonnenberg A, Schwartz JS, Cutler AF, Vakil N, Bloom BS. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies. Arch Intern Med 1998; 158: 852-860.
12. Lind T, Van Zaten SV, Unge P, Spiller R, Bayerdörffer E, O'Morain C et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 Study. Helicobacter 1996; 3: 138-144.
13. Lind T, Mégraud F, Unge P, Bayerdörffer E, O'Morain C, Spiller R et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with one-week triple therapies. Gastroenterology 1999; 116: 248-253.
14. De Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817-820.
15. Gisbert JP, Mur M, Boixeda D, Ceña G, Martín de Argila C, Alvarez I et al. Tratamiento con omeprazol, claritromicina y amoxicilina durante una semana: elevada eficacia en la erradicación de Helicobacter pylori y en la cicatrización de la úlcera duodenal. Med Clin (Barc) 1997; 108: 524-529.
16. Comet R, Calvet X, Navarro M, Garcia N, Sanfeliu I. Omeprazol, claritromicina y amoxicilina durante 7 días en el tratamiento de la infección por Helicobacter pylori. Gastroenterol Hepatol 1998; 21: 81-83.
17. Martín Mir ML, Val J, Fuentes J, García S, Yus C, Simón MA, Gomollón F. Efectividad en la erradicación de Helicobacter pylori de la pauta basada en omeprazol, amoxicilina y claritromicina. Gastroenterol Hepatol 1998; 21: 432-436.
18. Gomollón F, Ducons JA, Gimeno L, Fuentes J, Garcia S, Vera J et al. The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain. Helicobacter 1998; 3: 110-114.
19. Taylor JL, Zagari M, Murphy K, Freston JW. Pharmacoeconomic comparison of treatments for eradication of Helicobacter pylori. Arch Intern Med 1997; 157: 87-97.
20. Jovell AJ, Aymerich M, García-Altés A, Serrat-Prat M. Evaluación de la eficacia, seguridad y coste-efectividad del tratamiento erradicador de la infección por Helicobacter pylori asociado a úlcera duodenal. Barcelona: Agència d'Avaluació de Tecnologia Mèdica. Servei Català de la Salut, 1998.
21. El País. Anuario 1998. Madrid: Ed. El País, 1998.
22. a ed.). Madrid: Ed. MEDICOM, 1997.
23. Hodgson TA, Meiners MR. Cost of illness methodology: a guide to current practices and procedures. Milkbank memorial Found. Quarterly Health and Society 1982; vol. 60, no. 3.
24. Lamouliatte H, Cayla R. Helicobacter pylori eradication with one-week triple therapy: metaanalysis of French studies [resumen]. Gut 1998; 43 (Supl 3): 287.
25. Savarino V, Neri M, Vigneri S. PPI-Based triple therapy in the eradication of H. pylori [carta]. Gastroenterology 1999; 117: 746-747.
26. Calvet X, López-Lorente MT, Cubells MJ, Baré M, Gálvez E, Molina E. Two-week dual vs one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicenter, randomized trial. Aliment Pharmacol Ther 1999; 13: 781-785.
27. De Boer WA, Van Etten RJXM, Schade RWB, Ouwehand ME, Schneeberger PM, Tytgat GNJ et al. 4-day lansoprazole quadruple therapy. A highly effective cure for Helicobacter pylori infection. Am J Gastroenterol 1996; 91: 1778-1782.
28. Ducóns JA, Santolaria S, Guirao R, Ferrero M, Montoro M, Gomollón F. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of one-week lansoprazole, amoxycilin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther 1999; 13: 775-780.
29. Kadayifçi A, Simsek H. Does smoking influence the eradication of Helicobacter pylori and duodenal ulcer healing with different regimens? Int J Clin Pract 1997; 51: 516-517.
30. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ, Klein PD et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-496.
31. Van der Hulst RWM, Van der Ende A, Homan A, Roorda P, Dankert J, Tytgat GNJ. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut 1998; 42: 156-169.
32. Treiber G. The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. Am J Gastroenterol 1996; 91: 246-257.
33. Forné M, Viver JM, Esteve M, Fernández-Bañares F, Lite J, Espinós JC et al. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing. Am J Gastroenterol 1998; 93: 35-38.
34. Baena Díez JM, Sancho Perpiñán A, López Mompó C, Rams Rams F, Jiménez Navarrete S, Comet Jaumet D. Tratamiento con omeprazol, claritromicina y amoxicilina durante una semana. Efectividad y tolerancia en la erradicación de Helicobacter pylori en atención primaria. Aten Primaria 1998; 22: 547-551.
35. Lerang F, Moum B, Ranghildstveit E, Sandrei PK, Tolas P, Whist JE et al. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience for clinical practice in a population with a high frequency of metronidazole resistance. Am J Gastroenterol 1998; 93: 212-216.
36. Elizalde JR, Borda F, Jara C, Martinez A, Rodríguez C, Jiménez J. Eficacia de dos tratamientos consecutivos en la erradicación de Helicobacter pylori. An Sis San Navarra 1998; 21 (Supl 2): 83-88.